TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nikkiso Co., Ltd. ( (JP:6376) ) has shared an update.
Nikkiso Co., Ltd. has decided to cancel its planned construction of a new medical factory in Miyazaki, Japan, originally intended to enhance the production of blood tubing lines. This decision comes after a comprehensive review revealed that increased construction costs and advancements in overseas production capabilities made the project economically unviable. The company assures that the cancellation will not impact its financial performance and emphasizes its commitment to maintaining a stable supply of high-quality products through its enhanced overseas production sites.
The most recent analyst rating on (JP:6376) stock is a Buy with a Yen1654.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
More about Nikkiso Co., Ltd.
Nikkiso Co., Ltd. operates in the medical industry, focusing on the production of essential disposable parts for hemodialysis therapy, such as blood tubing lines. The company is committed to strengthening its production and supply systems, particularly for the Japanese market.
Average Trading Volume: 234,060
Technical Sentiment Signal: Buy
Current Market Cap: Yen93.22B
For an in-depth examination of 6376 stock, go to TipRanks’ Overview page.